585 related articles for article (PubMed ID: 25518736)
41. Wiskott-Aldrich syndrome protein and platelets.
Oda A; Ochs HD
Immunol Rev; 2000 Dec; 178():111-7. PubMed ID: 11213795
[TBL] [Abstract][Full Text] [Related]
42. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
[TBL] [Abstract][Full Text] [Related]
43. Studies of the expression of the Wiskott-Aldrich syndrome protein.
Stewart DM; Treiber-Held S; Kurman CC; Facchetti F; Notarangelo LD; Nelson DL
J Clin Invest; 1996 Jun; 97(11):2627-34. PubMed ID: 8647957
[TBL] [Abstract][Full Text] [Related]
44. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells.
Andreu N; Aran JM; Fillat C
Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274
[TBL] [Abstract][Full Text] [Related]
45. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction.
Wada T; Jagadeesh GJ; Nelson DL; Candotti F
Hum Gene Ther; 2002 Jun; 13(9):1039-46. PubMed ID: 12067437
[TBL] [Abstract][Full Text] [Related]
46. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
Huang W; Ochs HD; Dupont B; Vyas YM
J Immunol; 2005 Mar; 174(5):2602-11. PubMed ID: 15728466
[TBL] [Abstract][Full Text] [Related]
47. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome.
Gulácsy V; Freiberger T; Shcherbina A; Pac M; Chernyshova L; Avcin T; Kondratenko I; Kostyuchenko L; Prokofjeva T; Pasic S; Bernatowska E; Kutukculer N; Rascon J; Iagaru N; Mazza C; Tóth B; Erdos M; van der Burg M; Maródi L;
Mol Immunol; 2011 Feb; 48(5):788-92. PubMed ID: 21185603
[TBL] [Abstract][Full Text] [Related]
48. The open conformation of WASP regulates its nuclear localization and gene transcription in myeloid cells.
Looi CY; Sasahara Y; Watanabe Y; Satoh M; Hakozaki I; Uchiyama M; Wong WF; Du W; Uchiyama T; Kumaki S; Tsuchiya S; Kure S
Int Immunol; 2014 Jun; 26(6):341-52. PubMed ID: 24402308
[TBL] [Abstract][Full Text] [Related]
49. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
[TBL] [Abstract][Full Text] [Related]
50. Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment.
Sabri S; Foudi A; Boukour S; Franc B; Charrier S; Jandrot-Perrus M; Farndale RW; Jalil A; Blundell MP; Cramer EM; Louache F; Debili N; Thrasher AJ; Vainchenker W
Blood; 2006 Jul; 108(1):134-40. PubMed ID: 16522820
[TBL] [Abstract][Full Text] [Related]
51. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.
Toscano MG; Frecha C; Benabdellah K; Cobo M; Blundell M; Thrasher AJ; García-Olivares E; Molina IJ; Martin F
Hum Gene Ther; 2008 Feb; 19(2):179-97. PubMed ID: 18240968
[TBL] [Abstract][Full Text] [Related]
52. [Wiskott-Aldrich syndrome].
Gulácsy V; Maródi L
Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
[TBL] [Abstract][Full Text] [Related]
53. Successful renal transplantation in a patient with a Wiskott-Aldrich syndrome protein (WASP) gene mutation.
Chovancova Z; Kuman M; Vlkova M; Litzman J
Transpl Int; 2015 Aug; 28(8):1005-9. PubMed ID: 25864580
[TBL] [Abstract][Full Text] [Related]
54. A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.
Olivier A; Jeanson-Leh L; Bouma G; Compagno D; Blondeau J; Seye K; Charrier S; Burns S; Thrasher AJ; Danos O; Vainchenker W; Galy A
Mol Ther; 2006 Apr; 13(4):729-37. PubMed ID: 16360341
[TBL] [Abstract][Full Text] [Related]
55. Analyses of Genetic and Clinical Parameters for Screening Patients With Inherited Thrombocytopenia with Small or Normal-Sized Platelets.
Ouchi-Uchiyama M; Sasahara Y; Kikuchi A; Goi K; Nakane T; Ikeno M; Noguchi Y; Uike N; Miyajima Y; Matsubara K; Koh K; Sugita K; Imaizumi M; Kure S
Pediatr Blood Cancer; 2015 Dec; 62(12):2082-8. PubMed ID: 26175287
[TBL] [Abstract][Full Text] [Related]
56. Normal Arp2/3 complex activation in platelets lacking WASp.
Falet H; Hoffmeister KM; Neujahr R; Hartwig JH
Blood; 2002 Sep; 100(6):2113-22. PubMed ID: 12200375
[TBL] [Abstract][Full Text] [Related]
57. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
58. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome.
Boztug K; Germeshausen M; Avedillo Díez I; Gulacsy V; Diestelhorst J; Ballmaier M; Welte K; Maródi L; Chernyshova L; Klein C
Clin Genet; 2008 Jul; 74(1):68-74. PubMed ID: 18479478
[TBL] [Abstract][Full Text] [Related]
59. Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages.
Tsuboi S; Meerloo J
J Biol Chem; 2007 Nov; 282(47):34194-203. PubMed ID: 17890224
[TBL] [Abstract][Full Text] [Related]
60. Wiskott-Aldrich syndrome with macrothrombocytopenia.
Skoric D; Dimitrijevic A; Cuturilo G; Ivanovski P
Indian Pediatr; 2014 Dec; 51(12):1015-6. PubMed ID: 25560165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
